BRISTOL MYERS SQUIBB CO Intangible Assets 2007-2026 | BMY
Beta
What is intangible assets?
Intangible assets include non-physical assets such as patents, trademarks, copyrights, and customer relationships.
What is BRISTOL MYERS SQUIBB CO's current intangible assets?
BRISTOL MYERS SQUIBB CO (BMY) annual intangible assets for 2025 was $19.10B, a 18.04% decline from 2024. BRISTOL MYERS SQUIBB CO intangible assets for the quarter ending March 31, 2026 was $18.24B.
What was BRISTOL MYERS SQUIBB CO's intangible assets in 2024?
BRISTOL MYERS SQUIBB CO annual intangible assets for 2024 was $23.31B, a 13.91% decline from 2023.
What was BRISTOL MYERS SQUIBB CO's intangible assets in 2023?
BRISTOL MYERS SQUIBB CO annual intangible assets for 2023 was $27.07B, a 24.50% decline from 2022.
What is BRISTOL MYERS SQUIBB CO's 5-year intangible assets CAGR?
BRISTOL MYERS SQUIBB CO intangible assets grew at a compound annual growth rate (CAGR) of 18.54% from FY2020 to FY2025, going from $53.24B to $19.10B over 5 years.
Intangible Assets History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGR-18.5%
FY2020
$53.24B
→
FY2025
$19.10B
07080910111213141516171819202122232425
5 years selected
Intangible Assets History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $19.10B | -18.0% | 10-K |
| FY2024 | $23.31B | -13.9% | 10-K |
| FY2023 | $27.07B | -24.5% | 10-K |
| FY2022 | $35.86B | -15.7% | 10-K |
| FY2021 | $42.53B | -20.1% | 10-K |
| FY2020 | $53.24B | -16.8% | 10-K |
| FY2019 | $63.97B | +5763.3% | 10-K |
| FY2018 | $1.09B | -9.8% | 10-K |
| FY2017 | $1.21B | -12.6% | 10-K |
| FY2016 | $1.39B | -2.4% | 10-K |
| FY2015 | $1.42B | -19.1% | 10-K |
| FY2014 | $1.75B | -24.4% | 10-K |
| FY2013 | $2.32B | -73.6% | 10-K |
| FY2012 | $8.78B | +181.0% | 10-K |
| FY2011 | $3.12B | -7.3% | 10-K |
| FY2010 | $3.37B | +17.6% | 10-K |
| FY2009 | $2.87B | +148.9% | 10-K |
| FY2008 | $1.15B | -13.5% | 10-K |
| FY2007 | $1.33B | - | 10-K |
Company: BRISTOL MYERS SQUIBB COTicker: BMYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →